In TME, CAFs can regulate tumor progression and immunity by producing growth factors, cytokines, and chemokines, including CCL2, CCL5, CSF1, CXCL5, CXCL9, CXCL10, and CCL5. This evidence concerns the gene CCL5 and neoplasm.